Sarah.theheartdoc

Sarah.theheartdoc Mum of 2, wife, heart doctor, enthusiastic optimist. Women in Cardiology Representative & founder of

We spend so much time talking about weight loss, but not nearly enough time talking about strength.The goal shouldn’t ju...
19/06/2026

We spend so much time talking about weight loss, but not nearly enough time talking about strength.

The goal shouldn’t just be getting smaller - it should be staying healthy, mobile and independent for as long as possible.

Muscle protects your body as you age. It supports your heart health, bone health, balance, metabolism and overall quality of life.

And contrary to what many people think, having a heart condition doesn’t always mean avoiding weights completely. In many cases, appropriately prescribed resistance training can be incredibly beneficial.

Start where you are. Lift what you can. Build from there 💪

15/06/2026

Cardiology, nephrology, obesity medicine and diabetes care are no longer living in separate lanes.

Some of the biggest shifts happening in medicine right now are happening in the cardiorenal metabolic space - and the outcomes we’re seeing with therapies like finerenone and GLP-1 receptor agonists are changing how we think about cardiovascular and kidney disease entirely.

We’re now seeing treatments that can:
✔️ Reduce progression of chronic kidney disease
✔️ Lower heart failure hospitalisations
✔️ Improve cardiovascular outcomes
✔️ Support obesity-related heart failure
✔️ Target the metabolic drivers behind disease

In the latest episode of BeatWise The Podcast, I sit down with Dr. Andrew Frankel to discuss the shared pillars of cardiorenal medicine - and why this field is evolving so quickly.

I also recently recorded a fascinating episode with Dr. Muthu Vaduganathan discussing finerenone, metabolic therapies, and where the future of cardiorenal medicine is heading.

If this area interests you, I’d also highly recommend the Kidney Sake podcast for more brilliant conversations around kidney health and cardiorenal care.

12/06/2026

Most people still think of heart disease, kidney disease and metabolic disease as completely separate conversations.

But what if they’re actually all part of the same process?

In this week’s episode of Beatwise, I sat down with Dr Andrew Frankel to talk about the future of cardiorenal metabolic care, the treatments changing outcomes across specialties and why “creatinine fear” may be holding patients back from life-saving therapy.

We also get into:
• the therapies reshaping modern care
• why integrated CRM clinics matter
• the real role of GLP-1s beyond weight loss
• practical prescribing pearls clinicians need to know

A really important conversation for anyone interested in heart failure, CKD, diabetes or the future of preventative medicine.

Comment PODCAST and I’ll send you the link 🎧

09/06/2026

Hypertrophic Cardiomyopathy treatment is changing quickly.

For years, we largely focused on managing the consequences of hypertrophic cardiomyopathy - symptoms, LVOT obstruction, gradients and invasive procedures where needed.

But the landscape is changing.

We now have disease-specific therapies like cardiac myosin inhibitors, targeting the underlying hypercontractility in obstructive HCM.

And beyond that, the growing field of cardio-metabolic therapies is opening up a whole new way of thinking about heart failure, HFpEF and HCM - not just treating haemodynamics, but targeting biology, metabolism and disease mechanisms themselves.

This is where the future of cardiology is heading.

For more on hypertrophic cardiomyopathy, listen to BeatWise The Podcast, available on all major platforms.

Delighted to become one of the inaugural Fellows of the British Cardiovascular Society (FBCS).A huge honour and one that...
07/06/2026

Delighted to become one of the inaugural Fellows of the British Cardiovascular Society (FBCS).

A huge honour and one that reflects the support of many incredible mentors, colleagues, collaborators, and patients throughout my career.

From medical school in Germany to cardiology training in the UK, a DPhil in Oxford, heart failure and imaging fellowships, research in Boston, education, and service development — it has been quite a journey.

Grateful for the opportunity to contribute to a specialty I love, and excited for what comes next.

Amyloidosis

05/06/2026

This week is World Heart Rhythm Week led by the Arrhythmia Alliance — an important reminder that heart rhythm disorders affect millions of people worldwide, yet many remain undiagnosed until serious complications occur.

Palpitations, dizziness, blackouts, breathlessness, fatigue, or an irregular pulse should never simply be ignored as “stress” or “just getting older.”

Early recognition of arrhythmias can:

* prevent stroke,
* reduce heart failure,
* improve quality of life,
* and in some cases save lives.

As cardiologists we often think of arrhythmias as ECGs, ablations, and devices — but for patients these conditions affect confidence, work, exercise, mental health, and day-to-day living.

One of the most important things we can do is raise awareness and encourage people to seek medical advice early.

So this :
❤️ know your pulse
❤️ listen to symptoms
❤️ talk about palpitations
❤️ and never underestimate the importance of heart rhythm health

Thank you to the incredible work of the Arrhythmia Alliance in improving awareness, education, and patient support worldwide.

Cardiology HeartHealth Electrophysiology StrokePrevent

Address

Portsmouth

Website

Alerts

Be the first to know and let us send you an email when Sarah.theheartdoc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Sarah.theheartdoc:

Shortcuts

Share

Category